Development and Efficacy Evaluation of a Novel Nano-Emulsion Adjuvant for a Foot-and-Mouth Disease Virus-like Particles Vaccine Based on Squalane.

Nanomaterials (Basel) · 2022 · PMC9698784 · PMID 36432220

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Differences at 0.01 < p ≤ 0.05 were considered statistically significant, whereas those at p ≤ 0.01 were considered highly significant. 3.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.